A new study published in the Iranian Journal of Basic Medical Sciences, and published online by the U.S. National Institute of Health, has found that cannabinoids can help treat neuropathic pain caused by diabetes.
“Diabetic neuropathy (DN) is a common complication of diabetes that leads to allodynia, impaired nerve conduction, and progressive sensory loss”, state’s the study’s abstract. “The aim of this study was to observe the effect of a high-affinity cannabinoid receptors agonist, WIN 55,212-2 [meant to mimic the effects of cannabis], on thermal hyperalgesia, nerve conduction velocity and sciatic nerve histopathology in diabetic rats.”
Using diabetic rats injected with the synthetic cannabinoid, the researcher’s data shows “that cannabinoids have potent antinociceptive effects through direct actions in the spinal dorsal horn of nociceptive pathway. This suggests that intrathecally administered cannabinoids may offer hopeful strategies for the treatment of diabetic neuropathic pain.”
The full study can be found by clicking here.
According to a study released last year, individuals with a history of cannabis use are less likely to have diabetes. The study, published in the journal Epidemiology, found cannabis consumers to be 30% less likely to have diabetes compared to those who have never consumed the plant.